DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Colorectal Cancer Patient Insights and Epidemiology - 2016" report to their offering.
The latest survey US Colorectal Cancer Patient Insights and Epidemiology - 2016, provides insights into total Colorectal Cancer patients on drug therapies in US, Colorectal Cancer treatable patients, and Colorectal Cancer epidemiology in US. Epipatients conducted an online survey of Colorectal Cancer specialists, oncologists, and Colorectal Cancer patients to identify the Colorectal Cancer patients in US who were treated by drug therapies. The research also identifies total Colorectal Cancer patients' on drug therapies by Colorectal Cancer stages.
Colorectal cancer patients were given chemotherapies as a part of their treatment. This study accurately determines and forecast Colorectal Cancer patients who were on drug therapies in a given year. This research also provides insights into Colorectal Cancer epidemiology including Colorectal Cancer incidence and Colorectal Cancer prevalence by Colorectal Cancer stages I-IV.
Key Questions Answered:
- Colorectal Cancer Incidence in US by staging - Stage I, Stage II, Stage III, and Stage IV
- Colorectal Cancer Prevalence in US (10-year) by staging - Stage I, Stage II, Stage III, and Stage IV
- Colorectal Cancer Treatable Patients in US by staging - Stage I, Stage II, Stage III, and Stage IV
- Colorectal Cancer Patients on drug therapies by stages - Stage I, Stage II, Stage III, and Stage IV
- Base Year - 2015, Historic from 2010 and forecast to 2025
Key Topics Covered:
1. Methodology
2. Colorectal Cancer Incidence in US
3. Colorectal Cancer Prevalence in US
4. Colorectal Cancer Treatable Patients in US
5. Colorectal Cancer Patients on Drug Therapies in US
6. Glossary
For more information visit http://www.researchandmarkets.com/research/xqxnwp/us_colorectal
